Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1264)
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,398
Price
$576.37
Total Value
$805.77K
Shares Held After
23,603
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,683
Price
$573.57
Total Value
$965.31K
Shares Held After
47,353
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,010
Price
$575.41
Total Value
$581.16K
Shares Held After
25,001
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
977
Price
$572.41
Total Value
$559.24K
Shares Held After
49,036
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
442
Price
$574.09
Total Value
$253.75K
Shares Held After
26,011
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,543
Price
$573.45
Total Value
$884.83K
Shares Held After
26,453
% of Holdings
5.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
880
Price
$572.33
Total Value
$503.65K
Shares Held After
27,996
% of Holdings
3.0%
Warby Parker Inc. (WRBY)
Blumenthal Neil Harris — Director
Shares
22,442
Price
$25.09
Total Value
$563.07K
Shares Held After
50,165
% of Holdings
30.9%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
40,690
Price
$3.88
Total Value
$157.97K
Shares Held After
12,114,700
% of Holdings
0.3%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
15,000
Price
$23.61
Total Value
$354.15K
Shares Held After
362,152
% of Holdings
4.0%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
2,948
Price
$44.52
Total Value
$131.24K
Shares Held After
2,964,774
% of Holdings
0.1%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
2,948
Price
$44.52
Total Value
$131.24K
Shares Held After
2,964,774
% of Holdings
0.1%
Zivo Bioscience, Inc. (ZIVO)
STROME MARK E — 10% Owner
Shares
100,000
Price
$2.00
Total Value
$200.00K
Shares Held After
572,942
% of Holdings
17.5%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
750
Price
$199.59
Total Value
$149.69K
Shares Held After
20,282
% of Holdings
3.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
750
Price
$199.66
Total Value
$149.75K
Shares Held After
20,282
% of Holdings
3.6%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
52,397
Price
$44.68
Total Value
$2.34M
Shares Held After
2,967,722
% of Holdings
1.7%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
52,397
Price
$44.68
Total Value
$2.34M
Shares Held After
2,967,722
% of Holdings
1.7%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,441
Price
$48.06
Total Value
$117.30K
Shares Held After
25,000
% of Holdings
8.9%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,419
Price
$47.39
Total Value
$114.64K
Shares Held After
27,441
% of Holdings
8.1%
Planet 13 Holdings Inc. (PLNH)
Wren Chris — VP of Operations
Shares
2,500
Price
$0.15
Total Value
$383.50
Shares Held After
5,107,784
% of Holdings
0.0%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
140
Price
$45.81
Total Value
$6.41K
Shares Held After
29,860
% of Holdings
0.5%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
426,005
Price
$40.32
Total Value
$17.18M
Shares Held After
6,709,228
% of Holdings
6.0%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
458,411
Price
$16.28
Total Value
$7.46M
Shares Held After
2,739,208
% of Holdings
14.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
416
Price
$31.33
Total Value
$13.03K
Shares Held After
69,792
% of Holdings
0.6%
SANUWAVE Health, Inc. (SNWV)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$20.46
Total Value
$102.31K
Shares Held After
10,000
% of Holdings
33.3%
SANUWAVE Health, Inc. (SNWV)
Opaleye Management Inc. — 10% Owner
Shares
11,267
Price
$20.46
Total Value
$230.54K
Shares Held After
955,000
% of Holdings
1.2%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.57
Total Value
$277.70K
Shares Held After
403,822
% of Holdings
4.5%
Nuvation Bio Inc. (NUVB)
Wentworth Kerry — CHIEF REGULATORY OFFICER
Shares
36,750
Price
$5.01
Total Value
$184.28K
Shares Held After
53,000
% of Holdings
40.9%
Nuvation Bio Inc. (NUVB)
Liu Dongfang — CHIEF MEDICAL OFFICER
Shares
50,000
Price
$5.02
Total Value
$251.00K
Shares Held After
18,000
% of Holdings
73.5%
Phreesia, Inc. (PHR)
Hui Yvonne — Principal Accounting Officer
Shares
1,327
Price
$9.28
Total Value
$12.31K
Shares Held After
24,664
% of Holdings
5.1%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
20,225
Price
$39.99
Total Value
$808.84K
Shares Held After
246,426
% of Holdings
7.6%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
18,667
Price
$96.50
Total Value
$1.80M
Shares Held After
262,692
% of Holdings
6.6%
Twist Bioscience Corp (TWST)
Laponis Adam — Chief Financial Officer
Shares
4,000
Price
$60.00
Total Value
$240.00K
Shares Held After
118,694
% of Holdings
3.3%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
211,974
Price
$20.29
Total Value
$4.30M
Shares Held After
4,332,799
% of Holdings
4.7%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
18,839
Price
$40.60
Total Value
$764.96K
Shares Held After
1,423,095
% of Holdings
1.3%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
34,636
Price
$0.73
Total Value
$25.28K
Shares Held After
177,821
% of Holdings
19.5%
Warby Parker Inc. (WRBY)
Blumenthal Neil Harris — Director
Shares
27,558
Price
$25.04
Total Value
$690.05K
Shares Held After
50,165
% of Holdings
35.5%
Warby Parker Inc. (WRBY)
Blumenthal Neil Harris — Director
Shares
47,655
Price
$24.29
Total Value
$1.16M
Shares Held After
50,165
% of Holdings
48.7%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
9,550
Price
$20.22
Total Value
$193.07K
Shares Held After
462,577
% of Holdings
2.0%
KalVista Pharmaceuticals, Inc. (KALV)
Piekos Brian — Chief Financial Officer
Shares
1,862
Price
$20.22
Total Value
$37.64K
Shares Held After
18,150
% of Holdings
9.3%
KalVista Pharmaceuticals, Inc. (KALV)
Sweeny Nicole — Chief Commercial Officer
Shares
1,862
Price
$20.22
Total Value
$37.64K
Shares Held After
51,391
% of Holdings
3.5%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
2,686
Price
$20.22
Total Value
$54.30K
Shares Held After
142,547
% of Holdings
1.8%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
40,114
Price
$3.57
Total Value
$143.25K
Shares Held After
12,074,010
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$592.30
Total Value
$118.46K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
121
Price
$591.10
Total Value
$71.52K
Shares Held After
40,713
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
777
Price
$590.28
Total Value
$458.65K
Shares Held After
40,834
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,088
Price
$589.32
Total Value
$1.23M
Shares Held After
41,611
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,072
Price
$588.44
Total Value
$1.22M
Shares Held After
43,699
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,715
Price
$587.49
Total Value
$1.01M
Shares Held After
45,771
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
888
Price
$586.21
Total Value
$520.56K
Shares Held After
47,486
% of Holdings
1.8%
Showing 301–350 of 1264 transactions (page 7 of 26)